AC Immune
Alain Pirlot is an experienced professional with a diverse background in business development and support roles. Currently serving as Executive Assistant to the CSO and CFO at AC Immune since February 2020, Alain has also operated as a Business Consultant since January 2019, aiding business owners in problem-solving and development initiatives. Prior experience includes roles as Strategic Partnerships Officer at IUCN, Executive Assistant to Bertrand Piccard at SOLARIMPULSE, and various business development positions in industries such as advanced machines and telecommunications. Alain holds a degree in Mechanics and Thermodynamics from EPFL, complemented by earlier educational achievements at Collège Champittet and Collège de l'Elysée.
This person is not in any teams
This person is not in any offices
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.